T. Rowe Price Associates’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-59,586
Closed -$2.31M 3030
2023
Q1
$2.31M Sell
59,586
-663,381
-92% -$21.4M ﹤0.01% 1419
2022
Q4
$15.6M Sell
722,967
-39,891
-5% -$834K ﹤0.01% 975
2022
Q3
$18.7M Buy
762,858
+208,614
+38% +$5.52M ﹤0.01% 925
2022
Q2
$9.11M Sell
554,244
-37,731
-6% -$733K ﹤0.01% 1336
2022
Q1
$15.9M Buy
591,975
+28,213
+5% +$595K ﹤0.01% 1290
2021
Q4
$18.7M Sell
563,762
-1,171,601
-68% -$44.3M ﹤0.01% 1301
2021
Q3
$73.8M Buy
1,735,363
+11,108
+0.6% +$597K 0.01% 879
2021
Q2
$101M Buy
1,724,255
+87,685
+5% +$5.22M 0.01% 776
2021
Q1
$88.8M Buy
1,636,570
+165,236
+11% +$9.19M 0.01% 813
2020
Q4
$87.1M Buy
1,471,334
+61,852
+4% +$3.24M 0.01% 775
2020
Q3
$72.8M Buy
+1,409,482
New +$63.1M 0.01% 753

Other funds holding OSH

T. Rowe Price Associates's OSH Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 59,586 shares — an estimated $2.31M sold.

T. Rowe Price Associates first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $101M in Q2 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 59,586 Oak Street Health, Inc. shares in Q2 2023, an estimated $2.31M.
  • T. Rowe Price Associates first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
  • T. Rowe Price Associates's Oak Street Health, Inc. position peaked at $101M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.